Overview Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD Status: Completed Trial end date: 2011-04-01 Target enrollment: Participant gender: Summary This study will evaluate clinical efficacy and safety of treatment with YY-162 in children with ADHD Phase: Phase 3 Details Lead Sponsor: Yuyu Pharma, Inc.